Beskrivning
| Land | Danmark |
|---|---|
| Lista | First North Denmark |
| Sektor | Hälsovård |
| Industri | Vård & Omsorg |
COMPANY ANNOUNCEMENT – No. 2025-15
Copenhagen, Denmark, 24 June 2025 – Brain+ A/S (Nasdaq First North: BRAINP)
On 10 June, Brain+ A/S (“Brain+” or the “Company”) announced that 374,698,266, corresponding to 85.1% of its warrants of series TO 5 (the ‘Warrants’) had been exercised for subscription of 374,698,266 new shares. At the same time, the Company announced the decision to carry out a directed issue of 105,520,741 new shares to cover guarantor commitments activated for the remaining 14.9% of the Warrants plus compensation to the guarantors (the “Directed Issue”). The TO 5 warrants were issued in connection with Brain+’ unit rights issue in March 2025. The new shares from both the Warrant exercise and the Directed Issue have now been registered with the Danish Business Authority and admitted for trading on Nasdaq First North Copenhagen from 30 June 2025.
After the completion and registration of the Warrant exercise and the Directed Issue with the Danish Business Authority, the number of shares in Brain+ have increased by 480,219,007 shares, from 652,720,007 shares to 1,132,939,014 shares, and the Company’s nominal share capital have increased by DKK 4,802,190.07, from DKK 6,527,200.07 to DKK 11,329,390.14.
The conversion of interim shares to ordinary shares in Brain+ from the Warrant exercise will be made on 1 July 2025. Application has been made to Nasdaq Copenhagen A/S for the new shares from the Warrants exercise and the Directed Issue to be admitted for trading on Nasdaq First North Copenhagen. It is expected that the first day of trading of the new shares will be on 30 June 2025.
Advisors
In connection with the warrant exercise, Sedermera Corporate Finance AB act as financial advisors to Brain+. HC Andersen Capital 2 ApS act as legal advisor. Euronext Securities is the issuing agent and Jyske Bank is the settlement agent.
For more information about the warrant exercise, please contact:
Sedermera Corporate Finance AB
Phone: +46 (0) 40 615 14 10
E-mail: cf@sedermera.se
www.sedermera.se
For more information about Brain+, please contact:
Devika Wood, CEO
Phone: +44 7429 280366
E-mail: devika@brain-plus.com
Or,
Hanne Vissing Leth, CFO
Phone: +45 53 88 99 02
E-mail: hanne@brain-plus.com
www.brain-plus.com
Certified Adviser